We investigated the role of intracellular iron on the capacity of Histoplasma capsulatum (Hc) yeasts to multiply within human macrophages (M+). Coculture of Hc-infected MO with the iron chelator deferoxamine suppressed the growth of yeasts in a concentration-dependent manner. The effect of deferoxamine was reversed by iron-saturated transferrin (holotransferrin) but not by iron-free transferrin (apotransferrin). Chloroquine, which prevents release of iron from transferrin by raising endocytic and lysosomal pH, induced human MO to kill Hc. The effect of chloroquine was reversed by iron nitriloacetate, an iron compound that is soluble at neutral to alkaline pH, but not by holotransferrin, which releases iron only in an acidic environment.
peritoneal MO (PM) suggest that acquisition of intracellular iron may be important for yeast survival. Thus, coculture of Hc-infected murine PM in the presence of the iron chelator deferoxamine suppresses the intracellular growth ofyeasts, and this effect is reversed by iron-saturated transferrin (holotransferrin) (8) . Furthermore , it has been suggested that one mechanism by which IFN-y-activated mouse PM (8) and IFNy-LPSactivated murine splenic MO (9) inhibit the intracellular growth ofHc is by the restriction ofintracellular iron. Likewise, Byrd and Horwitz (10, 11 ) have demonstrated that the intracellular multiplication of Legionella pneumophila in human monocytes is iron dependent. IFNy downregulates monocyte transferrin receptors and, therefore, suppresses intracellular growth of L. pneumophila by restricting the availability of iron (9) .
Although in conflict with one report (12) , we (7) and others (5) Yeasts. H. capsulatum strain G2 1 7B was maintained as described (1, 2) . Yeasts were grown in HMM medium ( 14) at 370C with orbital shaking at 150 rpm. After 2 d, they were harvested by centrifugation, washed three times in HBSS containing 20 mM Hepes and 0.25% BSA (HBSA), and resuspended to 30 ml in HBSA. Large aggregates were removed by centrifugation at 200g for 5 min at 40C. The top 2 ml was removed, and the single cell suspension obtained was standardized to 5 X 104/ml in RPMI 1640 containing 5% heat-inactivated FCS and 10 gg/ml of gentamicin (Sigma Chemical Co.) (2).
Monocyte preparation andculture. Human peripheral blood monocytes were prepared under sterile conditions by dextran sedimentation and Ficoll-Hypaque centrifugation as described previously ( 15 (6) . The remaining M0 were cultured in M199 (Gibco Laboratories) containing 10% human serum and 10 ,ug/ml gentamicin or in medium containing chloroquine. After 24 h of culture at 370C, medium was removed, the cells were washed, and the monolayers were fixed in glutaraldehyde. Coverslips were mounted cell side down onto microscope slides. The percentage of M0 containing one or more intracellular yeasts and the number of yeasts in 100 infected MO were enumerated by phase-contrast microscopy at a magnification of 1,000. There was no loss of adherent M0 during these experiments (4, 6).
Mice. 5-wk-old C57BL/6J male mice were purchased from Jackson Laboratories (Bar Harbor, ME). The mice were housed four to a cage and adapted to their environment for 1 wk before infection with Hc yeasts.
Injection ofmice with Hc yeasts and treatment with chloroquine. A single cell suspension of yeasts was prepared as described above. Mice were given an intravenous injection with either a sublethal inoculum ( 1 X 106) or a lethal inoculum ( 1.5 X 107) of Hc yeasts in a total volume of 0.2 ml in RPMI 1640 (16) . Chloroquine, prepared in RPMI 1640 and sterile filtered, was injected intraperitoneally in a total volume of 0.2 ml.
Organ culture for Hc. Spleens and livers from Hc-infected mice were removed aseptically, homogenized in HBSS, and were diluted serially. I00-Ml of homogenate was plated onto brain-heart infusion agar (2% wt/vol) supplemented with 1O% (vol/ vol) defibrinated sheep erythrocytes, 10 ,g/ml dextrose, and 0.1 Mg/ml cysteine hydrochloride. Plates were incubated at 30'C, and CFU were counted after 7-lOd (16 diprotic weak base that raises the pH of endocytic vesicles and lysosomes in eukaryotic cells ( 19) . It therefore prevents the release of iron from transferrin in a variety ofcell types including MO (19) (20) (21) (22) . Byrd and Horwitz ( 13) have shown that chloroquine inhibits the intracellular growth of L. pneumophila in human monocytes and that the effect of chloroquine is reversed by FeNTA, a compound in which iron remains soluble at neutral to alkaline pH (23) .
Since the multiplication of Hc yeasts in human MO is iron dependent, we tested the hypothesis that chloroquine, by virtue of its capacity to interfere with iron metabolism, would inhibit the intracellular growth of Hc yeasts in a manner similar to that reported for L. pneumophila ( 13) .
Monocyte and MO monolayers were infected with Hc yeasts and then were cultured for 24 h in medium alone or (23) . Addition of FeNTA to Hc-infected MO treated with chloroquine reversed the inhibition of yeast growth by chloroquine (Fig. 4) . At Treatment ofHc-infected mice with chloroquine reduces the number of organisms in the spleen and liver. These findings suggested that chloroquine might be effective against Hc in vivo. Therefore, C57BL/6 mice were injected intravenously with 1 x 106 Hc yeasts. 8 h later, chloroquine, 120 mg/kg, was given intraperitoneally and continued daily thereafter. Mice were killed on day 7. Chloroquine was well tolerated, and the mice maintained their normal eating and drinking habits.
Treatment of mice with chloroquine reduced the number of organisms in the spleens and livers by 9-and 15-fold, respectively (P < 0.01 as compared with controls, Wilcoxon rank sum test) (Table II) . In subsequent trials, groups of mice were given 40, 80, or 120 mg/kg of chloroquine 8 h after intravenous injection of yeasts and daily for 6 d. Each dose of chloroquine significantly reduced CFU in spleens and livers as compared with Hc-infected controls (Fig. 6) .
Additional studies were performed to determine the efficacy of chloroquine when administrated later in the course of infection. Mice were injected intravenously with 1 X 106 Hc yeasts, and therapy was initiated with chloroquine (120 mg/ kg) at 8 h, on day 3 or on day 5 after inoculation. Treatment was continued daily until mice were killed on day 7. After 7 d of treatment, the CFU in spleens and livers were reduced 17-and 7-fold, respectively (P < 0.01 ) (Table III) . After 4 d of treatment, CFU in the spleens and livers were reduced by five-and twofold, respectively (P < 0.05). In mice in which Hc were allowed to proliferate for 4 d before receiving only 2 d ofchloroquine therapy, the number oforganisms in the spleens still was reduced by 50%. Thus, the efficacy of chloroquine correlated with the length of treatment.
Treatment of Hc-infected mice with chloroquine protects them from a lethal inoculum of Hc yeasts. Although chloroquine was therapeutic against a sublethal challenge, we sought to determine if it could protect mice from a lethal inoculum of yeasts. 20 mice were given 1.5 X 107 yeasts. 8 h after inoculation, groups of 10 mice were treated either with 120 mg/kg of chloroquine or with RPMI. Chloroquine was continued daily (Fig. 7) . One mouse in the chloroquine-treated group died on day 3 from intraperitoneal hemorrhage secondary to trauma from injection. Of the remaining nine mice, three died on day 13, and six mice survived until day 40 when the experiment was terminated (Fig. 7) . Extensive cultures of the spleens and livers of the surviving mice yielded no growth of Hc.
Discussion
Iron is an essential element for the growth and metabolism of almost all living cells (24). Iron functions in the transport and storage of oxygen and as a catalyst in electron transport processes. Thus, the acquisition of iron from the host is critical for pathogenic microorganisms to successfully establish infection. Conversely, restriction of the availability of iron to invading microbes would be advantageous to the host (25) (26) (27) .
Despite the abundance ofiron in the mammalian host, free iron is very limited. Most of the iron is located intracellularly, making acquisition of iron by extracellular pathogens difficult. The small amount ofiron that is in body fluids is bound by the high affinity iron-binding glycoproteins transferrin and lactoferrin (28) . These host proteins may provide nonspecific nutritional immunity by restricting infective microbial growth through the deprivation of iron (25) (26) (27) . Thus, addition of unsaturated transferrin to culture medium inhibits the growth of Hc (29) and other fungi, including Candida albicans (30), Candida glabrata ( 31) , and Cryptococcus neoformans (32) .
During infection, iron availability is restricted further by the induction of hypoferremia, a manifestation of the acutephase response. The decrease in free iron is associated with an increase in serum transferrin and lactoferrin (26, (33) (34) (35) . The major mechanism whereby iron decreases in serum and concomitantly accumulates in the spleen and liver is by inhibition ofthe release ofiron from MO, which prevents its normal recycling to transferrin (36) . MO also initiate the synthesis of the iron storage protein ferritin, which enables MO to continue to acquire iron from ingested senescent erythrocytes (36) . Paradoxically, this response to infection may enhance the pathogenicity of intracellular parasites by providing them with sufficient iron to multiply successfully within Mo.
This study demonstrates that the availability of intracellular iron is critical for Hc yeasts to survive and multiply within the phagolysosomes of human Mo. Culture of Hc-infected human Mo with the iron chelator deferoxamine inhibited the intracellular growth of Hc yeasts. The effect of deferoxamine was reversed by FeNTA and holotransferrin but not by NTA or apotransferrin.
In M+, mobilization of iron from transferrin and ferritin is dependent upon an acidic environment in endocytic vesicles and lysosomes ( 17, 18, (37) (38) (39) . After the transferrin receptor binds diferric transferrin, the receptor-ligand complex is endocytized, and the endocytic vesicle is acidified. As the pH decreases from 7 to 6, ferric ions dissociate from transferrin and are distributed intracellularly. At pH 6, one of two ferric ions bound to transferrin dissociates, resulting in 50% iron saturation of transferrin. When the pH decreases to 5, the second ferric ion dissociates (40, 41 ). The unsaturated apotransferrin remains bound to the transferrin receptor and is recycled to the cell surface ( 18) . In contrast, iron that is bound to ferritin is released to the intermediate pool of the cell after ferritin is degraded in lysosomes (37, 38) . Chloroquine prevents the release of ferric ions from saturated iron transferrin (19) (20) (21) (22) and may prevent degradation of ferritin by acid proteases (39) by virtue of its ability to raise endocytic and lysosomal pH.
Coculture of Hc-infected human MO with 5-10 uM chloroquine induced M4 to kill Hc yeasts. The effect of chloroquine was reversed by FeNTA, an iron compound that is soluble in the neutral to alkaline pH range (23), but not by holotransferrin, which requires an acid pH to release ferric ions (40, 41 ) . NTA did not reverse the effect of chloroquine. Thus, iron, and not the parent compound, restored the capacity ofHc to multiply in the presence of chloroquine.
In a recent study, Eissenberg and Goldman (42) Second, the effectiveness of chloroquine in reducing the numbers ofyeasts in the spleens and livers correlated with the length of therapy. Third, 67% of mice given chloroquine were protected from a lethal inoculum of Hc yeasts, whereas all untreated mice were dead by day 11.
These studies confirm and extend the studies of Byrd and Horwitz ( 13) , who demonstrated that chloroquine inhibits the growth of L. pneumophila in human monocytes by restricting the availability of intracellular iron. Likewise, chloroquine inhibits the growth ofMycobacterium tuberculosis in human MO and also significantly enhances the effectiveness of isoniazid and pyrazinamide against intracellular M. tuberculosis (43) .
The mechanism by which chloroquine inhibits the intracellular growth of M. tuberculosis has not been explored. However, it seems likely that the effect of chloroquine may be mediated by restriction of the availability of intracellular iron.
Finally, it has been shown by other investigators that the ability of resident or elicited murine PM to kill Listeria monocytogenes (44) and to inhibit the replication of Trypanosoma cruzi amastigotes (45) also is dependent on the concentration of intracellular iron. Culture of T. cruzi-infected PM in the presence ofdesferrioxamine reduces the rate ofamastigote replication. Furthermore, T. cruzi-infected mice fed iron dextran to increase intracellular iron stores have an increased mortality rate. Conversely, depletion of host iron stores with desferroxamine and an iron-deficient diet reduce the pathogenicity of infection with T. cruzi (46) .
Chloroquine is absorbed rapidly and completely from the gastrointestinal tract and achieves concentrations in the liver, spleen, kidney, and lungs that are 200-700 times those obtained in serum (47 
